Blood Screening Market Insights: Exploring Business Opportunities, Growth Trends, and Competitive Outlook for 2023-2028
In February 2023, Thermo Fisher Scientific Inc. (US) acquired TIB Molbiol (Germany), to expand its PCR test portfolio with a wide range of assays for infectious diseases.
View full press release